| Literature DB >> 22266352 |
Fernanda F Cruz1, Mariana A Antunes, Soraia C Abreu, Lívia C Fujisaki, Johnatas D Silva, Débora G Xisto, Tatiana Maron-Gutierrez, Debora S Ornellas, Vanessa K Sá, Nazareth N Rocha, Vera L Capelozzi, Marcelo M Morales, Patricia R M Rocco.
Abstract
We hypothesized that bone marrow-derived mononuclear cell (BMDMC) therapy protects the lung and consequently the heart in experimental elastase-induced emphysema. Twenty-four female C57BL/6 mice were intratracheally instilled with saline (C group) or porcine pancreatic elastase (E group) once a week during 4 weeks. C and E groups were randomized into subgroups receiving saline (SAL) or male BMDMCs (2 × 10(6), CELL) intravenously 3h after the first saline or elastase instillation. Compared to E-SAL group, E-CELL mice showed, at 5 weeks: lower mean linear intercept, neutrophil infiltration, elastolysis, collagen fiber deposition in alveolar septa and pulmonary vessel wall, lung cell apoptosis, right ventricle wall thickness and area, higher endothelial growth factor and insulin-like growth factor mRNA expressions in lung tissue, and reduced platelet-derived growth factor, transforming growth factor-β, and caspase-3 expressions. In conclusion, BMDMC therapy was effective at modulating the inflammatory and remodeling processes in the present model of elastase-induced emphysema.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22266352 DOI： 10.1016/j.resp.2012.01.002
Source DB: PubMed Journal: Respir Physiol Neurobiol ISSN： 1569-9048 Impact factor: 1.931